No Data
No Data
No Data
Pharmarise Holdings: Summary of financial results for the 3rd quarter of the fiscal year ending May 31, 2019 [Japanese GAAP] (consolidated)
Pharmarise 9-Mos Loss Y272.00M Vs Net Y177.00M
Dai光 (24th) [Financial Results Schedule]
※The above Calendar is just a schedule and may be subject to change due to company circumstances.---------------------------------------March 24 (Monday) <3160> Daikou---------------------------------------March 25 (Tuesday) <2796> PharmaLize <6664> Optoelect-----------------------------
BOJ Seeks More Rate Hikes but Not in Rush, Deputy Governor Says -- 2nd Update
Pharmarise Holdings Swings to Loss in Six Months to November, 2024
Famarize plummets, caution over short-term supply-demand relationship deterioration due to the sale.
Famarize <2796.T> has plunged, temporarily falling by 33 yen to 500 yen. After the market closes on the 15th, it announced that it would conduct an off-market sale between the 22nd and the 28th. There seems to be concern about a deterioration in short-term supply and demand relations. The company will conduct a sale of 149,900 shares between the 22nd and the 28th. There is an intention to sell a certain quantity from Shareholders, and it was determined that this would contribute to improving the distribution status of Stocks, enhancing liquidity, and increasing the ratio of circulating Stocks. As of 10:39 AM, the stock price.